| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1097KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
ECASS researchers cannot recommend alteplase for stroke |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 3-4
Jo Barnes,
Preview
|
PDF (2132KB)
|
|
摘要:
IV alteplase [Actilyse®; Boehringer Ingelheim] improves functional and neurological outcome in a strictly defined target population of patients with acute ischaemic stroke. However, because of the risks associated with treatment and problems in identifying appropriate patients, ECASS (European Cooperative Acute Stroke Study) investigators emphasised that alteplase cannot currently be recommended for use in this indication. The first results from this controversial trial were presented at the 20th International Joint Conference on Stroke and Cerebral Circulation [Charleston, South Carolina, US; February 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
SPf66 malaria vaccine in demand - but is it too soon? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1061KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 5-6
&NA;,
Preview
|
PDF (2058KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
Surfactant improves neonatal survival without increasing cost |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 6-7
&NA;,
Preview
|
PDF (2039KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
Blood cell reinfusionvsBMT in the treatment of cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 7-7
&NA;,
Preview
|
PDF (979KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
A step towards successful xenotransplantation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1066KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
Improving transmucosal delivery of biopharmaceuticals |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 9-9
Robert Short,
Preview
|
PDF (1008KB)
|
|
摘要:
Delivering biopharmaceuticals across mucosal surfaces may offer several advantages over current injection techniques. Therapeutic efficacy may be increased, and patients are likely to favour methods that do not require injections. At an IIR Ltd meeting, ‘Successfully Exploiting the Commercial Potential of Drug Delivery Systems for New and Existing Therapeutics’ [London, UK; January 1995], Professor Lisbeth Illum from DanBioSyst UK, outlined some of the problems and solutions encountered in studies of the transmucosal delivery of polypeptide biopharmaceuticals.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
Oral renin inhibitor lowers BP |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 10-10
&NA;,
Preview
|
PDF (1112KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
Modified fibrosarcoma cells induce immunity |
| |
Inpharma Weekly,
Volume &NA;,
Issue 974,
1995,
Page 11-11
&NA;,
Preview
|
PDF (1017KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
